On May 16, 2023, Valence Discovery Inc., a Montreal based startup in the artificial intelligence (AI) drug-discovery space, was acquired for US$47.5 million by Recursion Pharmaceuticals, Inc.
A Fasken team composed of Adam Saskin, Kristian Zimmerman, Jonathan Raizenne, Gabriel Paquette, Samuel Francisque, Vincent Younan (M&A), Ryan Rabinovitch, Andrew Haikal, Youcef Belrachid (Tax), Rhonda Grintuch and Terry Kyle Lapierre (Labor & Employment) advised Valence Discovery Inc. in this transaction.
